{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:16:21Z","timestamp":1791778581311,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.molmed.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T08:46:03Z","timestamp":1275641163000},"page":"329-335","source":"Crossref","is-referenced-by-count":38,"title":["Tuberous sclerosis complex: linking cancer to metabolism"],"prefix":"10.1016","volume":"16","author":[{"given":"Virginie","family":"Mieulet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F","article-title":"Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development","volume":"220","author":"Lee","year":"2001","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.molmed.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molmed.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ceb.2009.10.007","article-title":"mTOR and cancer: many loops in one pathway","volume":"22","author":"Efeyan","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.cub.2009.09.058","article-title":"An emerging role of mTOR in lipid biosynthesis","volume":"19","author":"Laplante","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4161\/auto.5.5.8504","article-title":"Rapamycin inhibits mTORC1, but not completely","volume":"5","author":"Thoreen","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1083\/jcb.jcb.200206108","article-title":"Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent","volume":"159","author":"Jaeschke","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1101\/gad.13.24.3244","article-title":"Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico\/PI3-kinase signaling pathway","volume":"13","author":"Goberdhan","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ncb995","article-title":"Rheb is an essential regulator of S6K in controlling cell growth in Drosophila","volume":"5","author":"Stocker","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ncb996","article-title":"Rheb promotes cell growth as a component of the insulin\/TOR signalling network","volume":"5","author":"Saucedo","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BST0370223","article-title":"Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor","volume":"37","author":"Avruch","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.molmed.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"12783","DOI":"10.1074\/jbc.M809207200","article-title":"Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein","volume":"284","author":"Sato","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cub.2005.02.053","article-title":"Rheb binds and regulates the mTOR kinase","volume":"15","author":"Long","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Garami","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1101\/gad.1240504","article-title":"Tsc2 is not a critical target of Akt during normal Drosophila development","volume":"18","author":"Dong","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"e6305","DOI":"10.1371\/journal.pone.0006305","article-title":"Akt phosphorylates both Tsc1 and Tsc2 in Drosophila, but neither phosphorylation is required for normal animal growth","volume":"4","author":"Schleich","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1042\/bst0310592","article-title":"TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis","volume":"31","author":"Sampson","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.molmed.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/34432","article-title":"A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molmed.2010.05.001_bib32","first-page":"3659","article-title":"Inactivation of LKB1\/STK11 is a common event in adenocarcinomas of the lung","volume":"62","author":"Sanchez-Cespedes","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1083\/jcb.200408161","article-title":"Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis","volume":"167","author":"Manning","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","article-title":"Restraining PI3K: mTOR signalling goes back to the membrane","volume":"30","author":"Harrington","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molmed.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"27790","DOI":"10.1074\/jbc.M109.028860","article-title":"TSC2 deficiency increases PTEN via HIF1alpha","volume":"284","author":"Mahimainathan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Manning","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","article-title":"Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.1699608","article-title":"Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events","volume":"22","author":"Nardella","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.05.001_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ccr.2006.08.022","article-title":"Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner","volume":"10","author":"Skeen","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garcia-Martinez","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1042\/BJ20082202","article-title":"mTORC2 is the hydrophobic motif kinase for SGK1","volume":"416","author":"Yan","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2009.04.012","article-title":"AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer","volume":"16","author":"Vasudevan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2008.09.003","article-title":"Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration","volume":"8","author":"Polak","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1038\/sj.onc.1210520","article-title":"Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling","volume":"26","author":"Lackey","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2010.05.001_bib53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-4924-2-28","article-title":"Complexes between the LKB1 tumor suppressor, STRAD alpha\/beta and MO25 alpha\/beta are upstream kinases in the AMP-activated protein kinase cascade","volume":"2","author":"Hawley","year":"2003","journal-title":"J. Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib56","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2010.05.001_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.pharmtox.47.120505.105304","article-title":"AMP-activated protein kinase as a drug target","volume":"47","author":"Hardie","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2010.05.001_bib58","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2008.12.026","article-title":"Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation","volume":"33","author":"Zheng","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib60","doi-asserted-by":"crossref","first-page":"e4771","DOI":"10.1371\/journal.pone.0004771","article-title":"Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF","volume":"4","author":"Esteve-Puig","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2010.05.001_bib61","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2010.05.001_bib62","first-page":"400","article-title":"Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions","volume":"59","author":"Henske","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2010.05.001_bib63","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/sj.onc.1209851","article-title":"Frequent loss of chromosome 9, homozygous CDKN2A\/p14(ARF)\/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas","volume":"26","author":"Weber","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2010.05.001_bib64","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.410420215","article-title":"Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas","volume":"42","author":"Wienecke","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2010.05.001_bib65","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","article-title":"Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes","volume":"41","author":"Jiang","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molmed.2010.05.001_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-8-163","article-title":"Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma","volume":"8","author":"Chakraborty","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2010.05.001_bib67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2009.01.041","article-title":"Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia","volume":"33","author":"Xu","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.molmed.2010.05.001_bib68","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.1158\/0008-5472.CAN-05-1204","article-title":"Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas","volume":"65","author":"Bredel","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2010.05.001_bib69","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35090585","article-title":"Delineation of prognostic biomarkers in prostate cancer","volume":"412","author":"Dhanasekaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2010.05.001_bib70","doi-asserted-by":"crossref","first-page":"13790","DOI":"10.1073\/pnas.191502998","article-title":"Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses","volume":"98","author":"Bhattacharjee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2010.05.001_bib71","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.onc.1202854","article-title":"Mutation of the 9q34 gene TSC1 in sporadic bladder cancer","volume":"18","author":"Hornigold","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2010.05.001_bib72","first-page":"7652","article-title":"Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder","volume":"63","author":"Knowles","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2010.05.001_bib73","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bst0310597","article-title":"Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours","volume":"31","author":"Knowles","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.molmed.2010.05.001_bib74","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1158\/1078-0432.CCR-09-0898","article-title":"Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer","volume":"15","author":"Platt","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2010.05.001_bib75","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/onc.2009.452","article-title":"TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity","volume":"29","author":"Liang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2010.05.001_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib77","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.410440603","article-title":"Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography","volume":"44","author":"Chugani","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2010.05.001_bib78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2007.05.006","article-title":"S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase","volume":"5","author":"Aguilar","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2010.05.001_bib79","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","article-title":"Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis","volume":"29","author":"Ozcan","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib80","doi-asserted-by":"crossref","first-page":"32081","DOI":"10.1074\/jbc.M502876200","article-title":"Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity","volume":"280","author":"Hahn-Windgassen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2010.05.001_bib81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-4598-7-37","article-title":"Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain","volume":"7","author":"Mukherjee","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molmed.2010.05.001_bib82","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20080557","article-title":"Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2010.05.001_bib83","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib85","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib86","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","article-title":"Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2010.05.001_bib87","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2008.12.017","article-title":"mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice","volume":"15","author":"Guertin","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib88","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2010.05.001_bib89","doi-asserted-by":"crossref","first-page":"14484","DOI":"10.1074\/jbc.273.23.14484","article-title":"Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism","volume":"273","author":"Hara","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2010.05.001_bib90","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.90645.2008","article-title":"Amino acid regulation of TOR complex 1","volume":"296","author":"Avruch","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2010.05.001_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20061881","article-title":"A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling","volume":"403","author":"Findlay","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2010.05.001_bib92","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.molcel.2010.01.031","article-title":"PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR","volume":"37","author":"Yan","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2010.05.001_bib93","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molmed.2010.05.001_bib94","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ncb1753","article-title":"Regulation of TORC1 by Rag GTPases in nutrient response","volume":"10","author":"Kim","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2010.05.001_bib95","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.molcel.2009.06.033","article-title":"The Vam6 GEF controls TORC1 by activating the EGO complex","volume":"35","author":"Binda","year":"2009","journal-title":"Mol. Cell"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491410000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491410000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T16:25:33Z","timestamp":1544459133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491410000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1471491410000687"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2010.05.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}